Today: 21 March 2026
Subscribe
Browse Category

NASDAQ:FER 20 December 2025 - 21 December 2025

Ferrovial SE Stock (NASDAQ: FER) Outlook: Nasdaq-100 Entry, €800 Million Buyback and Analyst Forecasts (Dec. 21, 2025)

Ferrovial SE Stock (NASDAQ: FER) Outlook: Nasdaq-100 Entry, €800 Million Buyback and Analyst Forecasts (Dec. 21, 2025)

Ferrovial SE will join the Nasdaq-100 before U.S. markets open on Monday, December 22, 2025, becoming the first IBEX 35 company to do so. The stock last traded at $66.39 ahead of the index change. Ferrovial also announced an €800 million share buyback and a holiday cash dividend. Index inclusion is expected to drive trading volume as funds adjust holdings.
21 December 2025
·
Ferrovial SE Stock (NASDAQ: FER) News and Forecasts for Dec. 20, 2025: Nasdaq-100 Entry, €800M Buyback, Dividend, and the 2026 Outlook

Ferrovial SE Stock (NASDAQ: FER) News and Forecasts for Dec. 20, 2025: Nasdaq-100 Entry, €800M Buyback, Dividend, and the 2026 Outlook

Ferrovial will join the Nasdaq-100 on December 22, becoming the first IBEX 35-listed company in the index. The move follows the launch of an €800 million share buyback and a €0.077 per share cash dividend, both set for December. U.S. shares closed at $66.39 on December 19, with trading volume spiking to 61.8 million that day.
20 December 2025
··

Stock Market Today

  • Pfizer Ltd Stock Faces Challenges Amid Indian Pharma Market Shifts and Global Parent Pressures
    March 21, 2026, 1:21 AM EDT. Pfizer Ltd, the Indian arm of Pfizer Inc., is experiencing share price volatility on NSE and BSE due to sector-wide challenges and strategic shifts by its global parent. The stock trades near ?4,738, down 4% year-over-year, underperforming the Nifty Pharma index. Investor concerns include regulatory changes, supply chain issues, and premium valuations with a high price-to-earnings ratio over 177. Despite recent modest gains and vaccine launches like the 20-valent Pneumococcal vaccine, Pfizer Ltd faces execution risks within India's complex pharma landscape. Its market cap stands around ?24,300 crore. European investors, especially in Germany, Austria, and Switzerland, should monitor developments closely amid India's evolving healthcare market and regulatory environment.
Go toTop